Detalhe da pesquisa
1.
NLRP4 negatively regulates type I interferon response and influences the outcome in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy.
Cancer Sci
; 113(3): 838-851, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927309